[1]
|
Wyller, V.B. (2007) The chronic fatigue syndrome-an update. Acta Neurologica Scandinavica, 115, 7-14.
doi:10.1111/j.1600-0404.2007.00840.x
|
[2]
|
Prins, J.B., Van der Meer, J.W.M. and Bleijenberg G. (2006) Chronic fatigue syndrome. Lancet, 367, 346-355.
doi:10.1016/S0140-6736(06)68073-2
|
[3]
|
Orth, J.P. (1993) La fatigue au quotidien. Sante Edition Odile Jacob, 103-115.
|
[4]
|
Rouillon, F., Delhommeau, G. and Vinceneux, P. (1996) Le syndrome de fatigue chronique, Masson, Paris.
|
[5]
|
Fukuda, K., Straus, S.E., Hickie, I., Sharp, M.C., Dobbins, J.C. and Komaroff, A. (1994) The chronic fatigue syndrome: A comprehensive approach to its definition and study. Annals of Internal Medicine, 121, 953-959.
|
[6]
|
Harvey, S.B. and Wessely, S. (2009) Chronic fatigue syndrome: Identifying zebras amongst the horses. BMC Medicine, 7, 58. doi:10.1186/1741-7015-7-58
|
[7]
|
Wojcik, W., Armstrong, Kanaan, R. (2011) Chronic fatigue syndrome: labels, meanings and consequences. Journal of Psychosomatic Research, 70, 500-504.
doi:10.1016/j.jpsychores.2011.02.002
|
[8]
|
Van Houdenhove, B., Pae, C.U. and Luyten, P. (2010) Chronic fatigue syndrome: Is there a role for non-anti- depressant pharmacotherapy? Expert Opinion, 11, 215-223. doi:10.1517/14656560903487744
|
[9]
|
Boneva, R.S., Maloney, E.M., Lin, J.M., et al. (2011) Gynecological history in chronic fatigue syndrome: A population-based case-control study. Journal of Women’s Health, 20, 1. doi:10.1089/jwh.2009.1900
|
[10]
|
Bhui, K.S., Dinos, S., Ashby, D., Nazroo, J., Wessely, S. and White, P.D. (2011) Chronic fatigue syndrome in an ethnically diverse population: The influence of psychosocial adversity and physical inactivity. BMC Medicine, 9, 26. doi:10.1186/1741-7015-9-26
|
[11]
|
Nater, U.M., Jones, J.F., Lin, J.M.S, Maloney, E., Reeves, W.C. and Heim, C. (2010) Personality features and personality disorders in chronic fatigue syndrome: A population-based study. Psychotherapy and Psychosomatics, 79, 312-318. doi:10.1159/000319312
|
[12]
|
Jason, L.A., Richman, J.A., Rademaker, A.W., et al. (1999) A community-based study of chronic fatigue syn- drome. Archives of Internal Medicine, 159, 2129-2137.
doi:10.1001/archinte.159.18.2129
|
[13]
|
Afari. N. and Buchwald, D. (2003) Chronic fatigue syndrome: A review. American Journal of Psychiatry, 160, 221-236. doi:10.1176/appi.ajp.160.2.221
|
[14]
|
Fernandez, A.A., Martin, A.P., Martinez, M.I., et al. (2009) Chronic fatigue syndrome: Aetiology, diagnosis and treatment. BMC psychiatry, 9, S1.
doi:10.1186/1471-244X-9-S1-S1
|
[15]
|
Constant, E.I., Adam, S., Gillain, B., Lambert, M., Masquelier, E. and Seron, X. (2011) Cognitive deficits in patients with chronic fatigue syndrome compared to those with major depressive disorder and healthy controls. Clinical Neurology Neurosurgery, 113, 295-302.
doi:10.1016/j.clineuro.2010.12.002
|
[16]
|
Schrijvers, D., Van Den Eede, F., Maas, Y., Cosyns, P., Hulstijn, W. and Sabbe, B.G.C. (2009) Psychomotor functioning in chronic fatigue syndrome and major depressive disorder: A comparative study. Journal of Affective Disorders, 115, 46-53. doi:10.1016/j.jad.2008.08.010
|
[17]
|
Goodwin, L., White, P.D., Hotopf, M., Stanfeld, S.A. and Clark, C. (2011) Psychopathology and physical activity as predictors of chronic fatigue syndrome in the 1958 british birth cohort: A replication study of the 1946 and 1970 birth cohorts. Annals of Epidemiology, 21, 343-350.
doi:10.1016/j.annepidem.2010.12.003
|
[18]
|
Brown, M.M., Brown, A.A. and Jason, L.A. (2010) Illness duration and coping style in chronic fatigue syndrome. Psychological Reports, 106, 383-393.
doi:10.2466/pr0.106.2.383-393
|
[19]
|
Aaron, L.A., Burke, M.M. and Buchwald, D. (2000) Overlapping conditions among patients with chronic fatigue syndrome, fibromyalgia and temporomandibular disorder. Archives of Internal Medicine, 160, 221-227. doi:10.1001/archinte.160.2.221
|
[20]
|
Sullivan, A., Nord, C.E. and Evengard, B. (2009) Effect of supplement with lactic-acid producing bacteria on fatigue and physical activity in patients with chronic fatigue syndrome. Nutrition Journal, 8, 4.
doi:10.1186/1475-2891-8-4
|
[21]
|
Kato, K., Sullivan, P.F., Evengard, B. and Pedersen, N.L. (2006) Premorbid predictors of chronic fatigue. Archives of General Psychiatry, 63, 1267-1272.
|
[22]
|
Cho, H.J., Skowera, A., Cleare, A. and Wessely, S. (2006) Chronic fatigue syndrome: An update focusing on phenomenology and pathophysiology. Current Opinion in Psychiatry, 19, 67-73.
doi:10.1097/01.yco.0000194370.40062.b0
|
[23]
|
Albright, F., Light, K., Light, A., Bateman, .L and Cannon-Albright, L.A. (2011) Evidence for a heritable predisposition to chronic fatigue syndrome. BMC Neurology, 11, 62. doi:10.1186/1471-2377-11-62
|
[24]
|
Narita, M., Nishigami, N. and Narita, N. (2003) Association between serotonin transporter gene polymorphism and chronic fatigue syndrome. Biochemical and Biophysical Research Communications, 311, 264-266.
doi:10.1016/j.bbrc.2003.09.207
|
[25]
|
Saiki, T., Kawai, T., Morita, K., et al. (2008) Identification of marker genes for differential diagnosis of chronic fatigue syndrome. Molecular Medicine, 14, 599-607.
doi:10.2119/2007-00059.Saiki
|
[26]
|
de Lange, F.P., Kalkman, J.S., Bleijenberg, G., et al. (2005) Gray matter volume reduction in the chronic fatigue syndrome. Neuroimage, 26, 777-781.
doi:10.1016/j.neuroimage.2005.02.037
|
[27]
|
Lange, G., Steffner, T.J. and Cook, D.B., et al. (2005) Objective evidence of cognitive complaints in chronic fatigue syndrome: A Blod fMRI study of verbal working memory. Neuroimage, 26, 513-524.
doi:10.1016/j.neuroimage.2005.02.011
|
[28]
|
Natelson, B.H., Cohen, J.M., Brasloff, I. and Lee, H.J. (1993) A controlled study of brain magnectic resonance imaging in patients with fatiguing illnesses. Journal of the Neurological Sciences, 120, 213-217.
doi:10.1016/0022-510X(93)90276-5
|
[29]
|
Lange, G., Deluca, J., Maldijian, J.A., Lee, H.J., Tiersky, L.A. and Natelson, B.H. (1999) Brain MRI abnormalities exist in a subset of patients with chronic fatigue syndrome. Journal of the Neurological Sciences, 171, 3-7.
doi:10.1016/S0022-510X(99)00243-9
|
[30]
|
Hooper, M. (2007) Myalgic encephalomyelitis: A review with emphasis on key findings in biomedical research. Journal of Clinical Pathology, 60, 466-471.
doi:10.1136/jcp.2006.042408
|
[31]
|
Morinet, F. and Corruble, E. (in press) Chronic fatigue syndrome and viral infections. In: “Chronic Fatigue Syndrome,” InTech, Rijeka, Croatia.
|
[32]
|
Cameron, B., Hirschberg, D.L., Rosenberg-Hassan, Y., Ablashi, D. and Lloyd, A. (2010). Serum cytokine levels in postinfective fatigue syndrome. Clinical Infectious Diseases, 50, 278-280.
|
[33]
|
Lombardi, V.C., Ruschetti, F.W., Das Gupta, J., et al. (2009) Detection of an infectious retrovirus, XMRV, in blood cells of patients with chronic fatigue syndrome. Science, 326, 585-589. doi:10.1126/science.1179052
|
[34]
|
Van Kuppeveld, F.J.M., De Jong, A.S., Lanke, K.H., et al. (2010) Prevalence of xenotropic murine leukaemia virus-related virus in patients with chronic fatigue syndrome in the Netherlands: Retrospective analysis of samples from an established cohort. British Medical Journal, 340, c1018. doi:10.1136/bmj.c1018
|
[35]
|
Satterfield, B.C., Garcia, R.A., Jia, H., Tang, S., Zheng, H. and Switzer, W.M. (2011) Serologic and PCR testing of persons with chronic fatigue syndrome in the United States shows no association with xenotropic or polytropic murine leukemia virus-related viruses. Retrovirology, 8, 12. doi:10.1186/1742-4690-8-12
|
[36]
|
Furuta, R.A., Miyazawa, T., Sugiyama, T., et al. (2011) No association of xenotropic murine leukemia virus-related virus with prostate cancer or chronic fatigue syndrome in Japan. Retrovirology, 8, 20.
doi:10.1186/1742-4690-8-20
|
[37]
|
Groom, H.C.T., Boucherit, V.C., Makinson, K., et al. (2010) Absence of xenotropic murine leukaemia virus-related virus in UK patients with chronic fatigue syndrome. Retrovirology, 7, 10. doi:10.1186/1742-4690-7-10
|
[38]
|
Switzer, W.M., Jia, H., Hohn, O., et al. (2010) Absence of evidence of Xenotropic Murine Leukemia Virus-related virus infection I persons with Chronic Fatigue Syndrome and healthy controls in the United States. Retrovirology, 7, 57. doi:10.1186/1742-4690-7-57
|
[39]
|
Lo, S-C., Pripuzova, N. and Li, B., et al. (2010) Detection of MLV-related virus gene sequences in blood of patients with chronic fatigue syndrome and healthy blood donors. Proceedings of the National Academy of Sciences, 107, 36. doi:10.1073/pnas.1012780107
|
[40]
|
Fletche, M.A., Zeng, X.R., Maher, K., et al. (2010) Biomarkers in chronic fatigue syndrome: evaluation of natural killer, cell function and dipeptidyl peptidase IV/CD26. Plos One, 5, e10817.
|
[41]
|
Withehead, W.E., Palsson, O. and Jones, K.R. (2002) Systematic review of the comorbidity of irritable bowel syndrome with other disorders: What are the causes and implications? Gastroenterology, 122, 1140-1156.
doi:10.1053/gast.2002.32392
|
[42]
|
Reyes, M., Dobbins, J.G., Mawle, A.C., et al. (1996) Risk factors for CFS: A case control study. Journal of Chronic Fatigue Syndrome, 2, 17-33. doi:10.1300/J092v02n04_03
|
[43]
|
Moorkens, G., Wynants, H. and Abs, R. (1998) Effect of growth hormone treatment in patients with chronic fatigue syndrome: A preliminary study. Growth Hormone & IGF Research, 8, 131-133.
|
[44]
|
Vercoulen, J.H., Swanink, C.M., Zitman, F.G., et al. (1996) Randomised, double-blind, placebo-controlled study of fluoxetine in chronic fatigue syndrome. Lancet, 374, 858-861. doi:10.1016/S0140-6736(96)91345-8
|
[45]
|
Forsyth, L.M. and Preuss, H.G (1999) Therapeutic effects of oral NADH on the symptoms of patients with chronic fatigue syndrome. Annals of Allergy, Asthma, and Immunology, 82, 185-191.
|
[46]
|
Alegre. J., Roses, J.M., Javierre, C., Ruiz-Baques. A., Segundo, M.J. and De Sevilla, T.F. (2010) Nicotinamide adenine dinucleotide (NADH) in patients with chronic fatigue syndrome. Revista Clínica Espanola, 210, 284-288.
doi:10.1016/j.rce.2009.09.015
|
[47]
|
Sathyapalan, T., Beckett, S., Rigby, A.S., Mellor, D.D. and Atkin, S.L. (2010) High cocoa polyphenol rich chocolate may reduce the burden of the symptoms in chronic fatigue syndrome. Nutrition Journal, 9, 55.
doi:10.1186/1475-2891-9-55
|
[48]
|
White, P.D., Goldsmith, K.A., Johnson, A.L., et al. (2011) Comparison of adaptive pacing therapy, cognitive behavior therapy, graded exercise therapy and specialist medical care for chronic fatigue syndrome (PACE): A randomized trial. Lancet, 377, 823-836.
doi:10.1016/S0140-6736(11)60096-2
|
[49]
|
Chambers, D., Bagnal, A.M., Hempel, S. and Forbes, C. (2006) Interventions for the treatment, management and rehabilitation of patients with chronic fatigue syndrome/myalgic encephalomyelitis: An update systematic review. Journal of the Royal Society of Medicine, 99, 506-520.
doi:10.1258/jrsm.99.10.506
|
[50]
|
Deale, A., Chalder, T., Marks, I. and Wessely, S. (1997) Cognitive behavior therapy for chronic fatigue syndrome: A randomized controlled trial. American Journal of Psychiatry, 154, 408-414.
|
[51]
|
Nye, F. (2007) NICE clinical guideline 53—Chronic fatigue syndrome/myalgic encephalomyelitis (or encephalopathy).
http://www.nice.org.uk/nicemedia/live/11824/36193/36193.pdf
|
[52]
|
Van Houdenhove, B. and Luyten, P. (2009) Treatment of chronic fatigue syndrome: How to find a “new equilibrium”? Patient Education and Counseling, 77, 153-154. doi:10.1016/j.pec.2009.09.001
|